stable oral bpc 157 BPC-157 Capsules Injectable vs Oral BPC-157 |

In patients in the placebo-controlled studies of STS 6 mg/24 hours, the only adverse event with an incidence of twice that of the placebo group was application site reaction.55 In higher-dose studies (9 mg/24 hours or 12 mg/24 hours), adverse events with an incidence of at least twice that of placebo included insomnia (32% vs 7%), dry mouth (13% vs 6%), dizziness (14% vs 5%), nervousness (10% vs 4%), and abnormal dreams (5% vs 2%).55 Most adverse events were considered mild or moderate

It is not approved for medical, diagnostic, therapeutic, or veterinary use

At first I was worried about giving myself the injection only because I dont like needles

Its like filling the cars fuel tank: whatever excess is poured in, simply runs over

Grunert P

The most frequent is transient injection-site irritation